These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 7962541)
61. Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease. Acosta PL; Caballero MT; Polack FP Clin Vaccine Immunol; 2015 Dec; 23(3):189-95. PubMed ID: 26677198 [TBL] [Abstract][Full Text] [Related]
62. Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells. Kim KH; Lee YT; Hwang HS; Kwon YM; Jung YJ; Lee Y; Lee JS; Lee YN; Park S; Kang SM PLoS One; 2015; 10(10):e0139916. PubMed ID: 26468884 [TBL] [Abstract][Full Text] [Related]
63. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells. Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098 [TBL] [Abstract][Full Text] [Related]
64. Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses. Lee JS; Cho MK; Hwang HS; Ko EJ; Lee YN; Kwon YM; Kim MC; Kim KH; Lee YT; Jung YJ; Kang SM J Interferon Cytokine Res; 2014 Nov; 34(11):902-14. PubMed ID: 25051168 [TBL] [Abstract][Full Text] [Related]
65. Influence of Hydration Status on Changes in Plasma Cortisol, Leukocytes, and Antigen-Stimulated Cytokine Production by Whole Blood Culture following Prolonged Exercise. Svendsen IS; Killer SC; Gleeson M ISRN Nutr; 2014; 2014():561401. PubMed ID: 24967270 [TBL] [Abstract][Full Text] [Related]
66. Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications. Van Braeckel-Budimir N; Haijema BJ; Leenhouts K Front Immunol; 2013; 4():282. PubMed ID: 24062748 [TBL] [Abstract][Full Text] [Related]
67. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Graham BS Immunol Rev; 2011 Jan; 239(1):149-66. PubMed ID: 21198670 [TBL] [Abstract][Full Text] [Related]
68. Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses. Melendi GA; Bridget D; Monsalvo AC; Laham FF; Acosta P; Delgado MF; Polack FP; Irusta PM Virus Genes; 2011 Feb; 42(1):46-54. PubMed ID: 21053062 [TBL] [Abstract][Full Text] [Related]
69. Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection. Schuurhof A; Bont L; Pennings JL; Hodemaekers HM; Wester PW; Buisman A; de Rond LC; Widjojoatmodjo MN; Luytjes W; Kimpen JL; Janssen R J Virol; 2010 Sep; 84(18):9584-94. PubMed ID: 20592085 [TBL] [Abstract][Full Text] [Related]
70. Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Graham BS; Kines RC; Corbett KS; Nicewonger J; Johnson TR; Chen M; LaVigne D; Roberts JN; Cuburu N; Schiller JT; Buck CB Mucosal Immunol; 2010 Sep; 3(5):475-86. PubMed ID: 20555315 [TBL] [Abstract][Full Text] [Related]
72. TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity. Johnson TR; Rao S; Seder RA; Chen M; Graham BS Vaccine; 2009 May; 27(23):3045-52. PubMed ID: 19428918 [TBL] [Abstract][Full Text] [Related]
73. Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination. Castilow EM; Varga SM Future Virol; 2008; 3(5):445-454. PubMed ID: 19057653 [TBL] [Abstract][Full Text] [Related]
74. Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease. Castilow EM; Legge KL; Varga SM J Immunol; 2008 Nov; 181(10):6692-6. PubMed ID: 18981084 [TBL] [Abstract][Full Text] [Related]
75. Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein. Johnson TR; Rothenberg ME; Graham BS J Leukoc Biol; 2008 Sep; 84(3):748-59. PubMed ID: 18519743 [TBL] [Abstract][Full Text] [Related]
76. Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization. Tourdot S; Mathie S; Hussell T; Edwards L; Wang H; Openshaw PJ; Schwarze J; Lloyd CM Clin Exp Allergy; 2008 Jun; 38(6):1016-24. PubMed ID: 18498543 [TBL] [Abstract][Full Text] [Related]